Secondary prevention therapies following percutaneous coronary intervention or acute coronary syndrome in patients with diabetes mellitus
Diabetes mellitus (DM) promotes atherosclerosis, leading to increased risk for cardiovascular morbidity and mortality. Diabetics represent a challenging subset of patients undergoing percutaneous coronary intervention (PCI) or who have experienced an acute coronary syndrome (ACS), a subset character...
Saved in:
Main Authors: | Arnaud Planchat, Baris Gencer, Sophie Degrauwe, Yazan Musayeb, Marco Roffi, Juan F. Iglesias |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1436332/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Intravascular Imaging-Guided Percutaneous Coronary Intervention on Coronary Artery Perforation
by: Yuichi Sawayama, MD, et al.
Published: (2025-01-01) -
Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
by: Azhi ShaMa, MM, et al.
Published: (2024-12-01) -
Comparing percutaneous coronary intervention and coronary artery bypass grafting for left main stenosis on the basis of current regional registry evidenceCentral MessagePerspective
by: Hristo Kirov, MD, et al.
Published: (2024-12-01) -
Research progress on coronary slow flow or no-reflow of coronary heart disease undergoing percutaneous coronary intervention surgery
by: Mengdi Wang, et al.
Published: (2025-01-01) -
Long-term cardiovascular outcomes after percutaneous coronary intervention in patients with systemic sclerosis
by: Kazutoshi Hirose, et al.
Published: (2025-04-01)